Rapporto sull’analisi delle dimensioni del mercato dei dispositivi per la somministrazione di farmaci senza ago | Previsioni 2031

  • Report Code : TIPHE100001168
  • Category : Medical Device
  • Status : Data Released
  • No. of Pages : 150
Buy Now

PANORAMICA DEL MERCATO

I sistemi di somministrazione di farmaci senza ago sono un modo e un metodo innovativo di somministrazione di farmaci e altri tipi di medicinali. Possono anche essere forme di cerotti transdermici, sistemi di inalazione o anche micro-aghi che non perforano la pelle come un ago convenzionale. I pazienti affetti da diabete di tipo 1 necessitano di un monitoraggio regolare del glucosio e utilizzano aghi per la somministrazione di insulina, il che aumenta il rischio di infezione e dolore tra gli individui. I dispositivi senza ago garantiscono un parto meno doloroso e riducono il rischio di infezione. Di conseguenza, si prevede che la domanda di questi dispositivi aumenterà durante il periodo di previsione.

AMBITO DI MERCATO

L'"Analisi di mercato globale dei dispositivi per la somministrazione di farmaci senza ago fino al 2028" è uno studio specializzato e approfondito di l'industria alimentare e delle bevande con particolare attenzione all'analisi delle tendenze del mercato globale. L’obiettivo del rapporto è fornire una panoramica del mercato dei dispositivi per la somministrazione di farmaci senza ago con una segmentazione completa del mercato per tecnica, applicazione e area geografica. Il rapporto fornisce statistiche chiave sullo stato del mercato dei principali attori del mercato Dispositivi per la somministrazione di farmaci senza ago e offre tendenze e opportunità chiave nel mercato.

SEGMENTAZIONE DEL MERCATO

    •  In base alla tecnica, il mercato globale dei dispositivi per la somministrazione di farmaci senza ago è segmentato in inalatori, cerotti transdermici, iniettori a getto e nuovi dispositivi senza ago. •  In base all’applicazione, il mercato è segmentato in Iniezione pediatrica, Dispositivi per la somministrazione di insulina, Dispositivi per la somministrazione di vaccini, Altri.

DINAMICHE DEL MERCATO

Driver

    •  Aumento della prevalenza del diabete e delle malattie croniche. •  La crescente domanda di somministrazione indolore di farmaci. •  Progresso tecnologico nei dispositivi per la somministrazione di farmaci.

Restrizioni

    •  Costo elevato di questi dispositivi e rigoroso processo di approvazione normativa.

QUADRO REGIONALE

Il rapporto fornisce una panoramica dettagliata del settore, comprese informazioni sia qualitative che quantitative. Fornisce una panoramica e previsioni del mercato globale in base a vari segmenti. Fornisce inoltre stime sulle dimensioni del mercato e sulle previsioni per l’anno dal 2019 al 2028 rispetto a cinque regioni principali, vale a dire; Nord America, Europa, Asia-Pacifico (APAC), Medio Oriente e Africa (MEA) e Sud America. Il mercato dei dispositivi per la somministrazione di farmaci senza ago in ciascuna regione è successivamente suddiviso in sottosegmenti in base ai rispettivi paesi e segmenti. Il rapporto copre l’analisi e le previsioni di 18 paesi a livello globale insieme alla tendenza attuale e alle opportunità prevalenti nella regione. Il rapporto analizza i fattori che influenzano il mercato sia dal lato della domanda che dell'offerta e valuta ulteriormente le dinamiche di mercato che influenzano il mercato durante il periodo di previsione, ovvero fattori trainanti, restrizioni, opportunità e tendenza futura. Il rapporto fornisce anche un'analisi PEST esaustiva per tutte e cinque le regioni, vale a dire; Nord America, Europa, APAC, MEA e Sud America dopo aver valutato i fattori politici, economici, sociali e tecnologici che influenzano il mercato dei dispositivi per la somministrazione di farmaci senza ago in queste regioni.

IMPATTO DEL COVID-19 SUL MERCATO DEI DISPOSITIVI SENZA AGHI PER LA CONSEGNA DI FARMACI

Attualmente sono in corso numerosi programmi di sviluppo di vaccini contro il COVID 19 in tutto il mondo. Si spera che alcuni di questi vengano presto approvati per l’uso e avranno un impatto notevole. Parallelamente, i governi e le organizzazioni no-profit stanno effettuando investimenti significativi per creare capacità adeguate per la fornitura e la somministrazione di tali vaccini su scala nazionale e globale. Si prevede che la domanda di dispositivi per la somministrazione di farmaci senza ago aumenterà per la somministrazione di vaccini poiché questi dispositivi sono privi di rischi, sicuri ed efficaci. Ad esempio, nell’ottobre 2020, la FDA statunitense ha concesso l’autorizzazione all’immissione in commercio 510 (k) per i sistemi di iniezione senza ago sviluppati da PharmaJet per la sperimentazione del candidato vaccino COVID-19.

ATTORI DI MERCATO

Il rapporto copre gli sviluppi chiave nel mercato dei dispositivi per la somministrazione di farmaci senza aghi come strategie di crescita organica e inorganica. Diverse aziende si stanno concentrando su strategie di crescita organica come lanci di prodotti, approvazioni di prodotti e altri come brevetti ed eventi. Le attività delle strategie di crescita inorganica testimoniate nel mercato sono state acquisizioni, partnership e collaborazioni. Queste attività hanno aperto la strada all'espansione del business e della base clienti degli operatori del mercato. Si prevede che i contribuenti del mercato dei dispositivi per la somministrazione di farmaci senza ago avranno opportunità di crescita redditizie in futuro con la crescente domanda di dispositivi per la somministrazione di farmaci senza ago nel mercato globale. Il rapporto include anche i profili delle principali aziende insieme alle loro analisi SWOT e strategie di mercato nel mercato dei dispositivi per la somministrazione di farmaci senza aghi. Inoltre, il rapporto si concentra sui principali attori del settore con informazioni quali profili aziendali, componenti e servizi offerti, informazioni finanziarie degli ultimi 3 anni e lo sviluppo chiave degli ultimi cinque anni.
    •  Antares Pharma, Inc. •  Endo International plc. •  PharmaJet •  Bioject Medical Technologies Inc. •  Medical International Technology, Inc. •  INJEX Pharma AG •  National Medical Products Inc. •  Valeritas, Inc. •  Gruppo farmaceutico europeo •  PenJet Corporation
Il team di ricerca e analisi dedicato del partner Insight è composto da professionisti esperti con competenze statistiche avanzate e offre varie opzioni di personalizzazione nello studio esistente.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is needle-free drug delivery device?

Needle-free drug deliveries are taken in the form of power sprays, jet injectors, inhalers, and skin patches. Needle-free technology reduces patient concern about using needles. Needle-free devices are effective injections for a wide range of drugs and are bioequivalent to needles. Advantages of needle-free delivery devices include less pain, fast injection, no needle disposal issue, and can be self-administered. Thus, the benefits of needle-free drug delivery devices over conventional needles and syringes are mainly responsible for the increasing demand for needle-free drug delivery devices.

What are the driving and restraining factors for the needle-free drug delivery device market?

Increasing prevalence of chronic diseases and increasing needlestick injuries propels the needle-free drug delivery devices market growth. However, the high cost of development as compare to injections hinders the growth of the market.

Who are the major players in market the needle-free drug delivery device market?

The needle-free drug delivery device market majorly consists of the players such NuGen Medical Devices Inc, NovaXS Biotech, GlaxoSmithKline, AstraZeneca, Roche, Boehringer Ingelheim, Merck, Cipla, Novartis, Teva Pharmaceuticals, Omron Healthcare, Sumitomo Pharma Co., Ltd

Which segment is dominating the needle-free drug delivery device market?

Based on type, the needle-free drug delivery devices market is segmented into inhalers, jet injectors, novel needles, transdermal patches, and others.
By application, the market is segmented into insulin delivery, vaccination, pain management, and others. The insulin delivery disease segment dominated the market in 2023.

Which region is dominating the needle-free drug delivery device market?

Based on geography, the needle-free drug delivery device market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the largest contributor to the growth of the global needle-free drug delivery device market. Asia Pacific is expected to register the highest CAGR in the needle-free drug delivery device market during 2022–2030.

The List of Companies - Needle-Free Drug Delivery Devices Market 

  1. NuGen Medical Devices Inc
  2. NovaXS Biotech
  3. GlaxoSmithKline
  4. AstraZeneca
  5. Roche
  6. Boehringer Ingelheim
  7. Merck
  8. Cipla
  9. Novartis
  10. Teva Pharmaceuticals
  11. Omron Healthcare
  12. Sumitomo Pharma Co., Ltd

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports